Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

How much of a market is involved in a biodiversity offset? A typology of biodiversity offset policies.

Koh NS, Hahn T, Boonstra WJ.

J Environ Manage. 2019 Feb 15;232:679-691. doi: 10.1016/j.jenvman.2018.11.080. Epub 2018 Dec 4.

2.

Protective Role of Histidine Supplementation Against Oxidative Stress Damage in the Management of Anemia of Chronic Kidney Disease.

Vera-Aviles M, Vantana E, Kardinasari E, Koh NL, Latunde-Dada GO.

Pharmaceuticals (Basel). 2018 Oct 21;11(4). pii: E111. doi: 10.3390/ph11040111. Review.

3.

The CLER National Report of Findings 2018: Trends in the CLER Focus Areas.

Koh NJ, Wagner R, Newton RC, Casey BR, Sun H, Weiss KB; CLER Program.

J Grad Med Educ. 2018 Aug;10(4 Suppl):69-76. doi: 10.4300/1949-8349.10.4s.69. No abstract available.

PMID:
30154958
4.

Detailed Findings From the CLER National Report of Findings 2018.

Koh NJ, Wagner R, Newton RC, Casey BR, Sun H, Weiss KB; CLER Program.

J Grad Med Educ. 2018 Aug;10(4 Suppl):49-68. doi: 10.4300/1949-8349.10.4s.49. No abstract available.

PMID:
30154957
5.

The Methodology for the CLER National Report of Findings 2018.

Koh NJ, Wagner R, Sun H, Weiss KB; CLER Program.

J Grad Med Educ. 2018 Aug;10(4 Suppl):13-18. doi: 10.4300/1949-8349.10.4s.13. No abstract available.

PMID:
30154955
6.

The Overview of the CLER Program: CLER National Report of Findings 2018.

Wagner R, Newton RC, Casey BR, Koh NJ, Weiss KB; CLER Program.

J Grad Med Educ. 2018 Aug;10(4 Suppl):11-12. doi: 10.4300/1949-8349.10.4s.11. No abstract available.

PMID:
30154954
7.

Pericytoma With t(7;12): The First Ovarian Case Reported and a Review of the Literature.

Koh NWC, Seow WY, Lee YT, Lam JCM, Lian DWQ.

Int J Gynecol Pathol. 2018 Aug 6. doi: 10.1097/PGP.0000000000000542. [Epub ahead of print]

PMID:
30085941
8.

Allergic contact dermatitis caused by 2-hydroxyethyl acrylate in a moisturizing face pack in a handmade acrylic accessory enthusiast.

Mukaijo J, Inomata N, Higashihira M, Koh N, Togashi Y, Asai C, Watanabe Y, Kurihara S, Aihara M.

Contact Dermatitis. 2018 Dec;79(6):383-385. doi: 10.1111/cod.13088. Epub 2018 Aug 6. No abstract available.

PMID:
30079447
9.

Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression.

Sng MK, Chan JSK, Teo Z, Phua T, Tan EHP, Wee JWK, Koh NJN, Tan CK, Chen JP, Pal M, Tong BMK, Tnay YL, Ng XR, Zhu P, Chiba S, Wang X, Wahli W, Tan NS.

Cell Discov. 2018 Apr 3;4:15. doi: 10.1038/s41421-018-0014-5. eCollection 2018.

10.

Quantitative cerebrovascular pathology in a community-based cohort of older adults.

Rane S, Koh N, Boord P, Madhyastha T, Askren MK, Jayadev S, Cholerton B, Larson E, Grabowski TJ.

Neurobiol Aging. 2018 May;65:77-85. doi: 10.1016/j.neurobiolaging.2018.01.006. Epub 2018 Jan 31.

PMID:
29452984
11.

Current methods and limitations for longitudinal fMRI analysis across development.

Madhyastha T, Peverill M, Koh N, McCabe C, Flournoy J, Mills K, King K, Pfeifer J, McLaughlin KA.

Dev Cogn Neurosci. 2018 Oct;33:118-128. doi: 10.1016/j.dcn.2017.11.006. Epub 2017 Nov 22.

12.

Running Neuroimaging Applications on Amazon Web Services: How, When, and at What Cost?

Madhyastha TM, Koh N, Day TKM, Hernández-Fernández M, Kelley A, Peterson DJ, Rajan S, Woelfer KA, Wolf J, Grabowski TJ.

Front Neuroinform. 2017 Nov 3;11:63. doi: 10.3389/fninf.2017.00063. eCollection 2017.

13.

Early Impressions of the CLER Program: A Survey of the Designated Institutional Official Community.

Koh NJ, Wagner R, Sun H, Newton R, Casey BR, Weiss KB.

J Grad Med Educ. 2016 Jul;8(3):478-82. doi: 10.4300/JGME-D-16-00315.1. No abstract available.

14.

High-Sensitivity Troponin Assays: Boon or Bane for the Cardiologist?

Koh NS, Lim SH, Yeo CP, Tan JW.

Ann Acad Med Singapore. 2016 Jun;45(6):225-7. No abstract available.

15.

Detailed Findings from the CLER National Report of Findings 2016.

Wagner R, Koh NJ, Patow C, Newton R, Casey BR, Weiss KB; CLER Program.

J Grad Med Educ. 2016 May;8(2 Suppl 1):35-54. doi: 10.4300/1949-8349.8.2s1.35. No abstract available.

16.

The Methodology for the CLER National Report of Findings 2016.

Koh NJ, Wagner R, Weiss KB; CLER Program.

J Grad Med Educ. 2016 May;8(2 Suppl 1):15-9. doi: 10.4300/1949-8349.8.2s1.15. No abstract available.

17.

The Overview of the CLER Program: CLER National Report of Findings 2016.

Wagner R, Patow C, Newton R, Casey BR, Koh NJ, Weiss KB; CLER Program.

J Grad Med Educ. 2016 May;8(2 Suppl 1):11-3. doi: 10.4300/1949-8349.8.2s1.11. No abstract available.

18.

Using Make for Reproducible and Parallel Neuroimaging Workflow and Quality-Assurance.

Askren MK, McAllister-Day TK, Koh N, Mestre Z, Dines JN, Korman BA, Melhorn SJ, Peterson DJ, Peverill M, Qin X, Rane SD, Reilly MA, Reiter MA, Sambrook KA, Woelfer KA, Grabowski TJ, Madhyastha TM.

Front Neuroinform. 2016 Feb 2;10:2. doi: 10.3389/fninf.2016.00002. eCollection 2016.

19.

Observation of handover process in an intensive care unit (ICU): barriers and quality improvement strategy.

Kowitlawakul Y, Leong BS, Lua A, Aroos R, Wong JJ, Koh N, Goh N, See KC, Phua J, Mukhopadhyay A.

Int J Qual Health Care. 2015 Apr;27(2):99-104. doi: 10.1093/intqhc/mzv002. Epub 2015 Feb 2.

PMID:
25644706
20.

Differences in the handover process and perception between nurses and residents in a critical care setting.

Mukhopadhyay A, Leong BS, Lua A, Aroos R, Wong JJ, Koh N, Goh N, See KC, Phua J, Kowitlawakul Y.

J Clin Nurs. 2015 Mar;24(5-6):778-85. doi: 10.1111/jocn.12707. Epub 2014 Nov 25.

PMID:
25421502
21.

Neurophobia in medical students and junior doctors--blame the GIK.

Kam KQ, Tan GS, Tan K, Lim EC, Koh NY, Tan NC.

Ann Acad Med Singapore. 2013 Nov;42(11):559-66.

22.

Recurrent episodic hypoxaemic respiratory failure following a stroke.

Foo AS, Tan ZK, Lee E, Koh NY.

BMJ Case Rep. 2012 Aug 1;2012. pii: bcr2012006371. doi: 10.1136/bcr-2012-006371.

23.

An octogenarian with painless type A aortic dissection and cardiac tamponade.

Chin CW, Koh N, Wong A, Lai SH, Chao V.

Postgrad Med J. 2012 Dec;88(1046):729-30. doi: 10.1136/postgradmedj-2012-131008. Epub 2012 Jul 21. No abstract available.

PMID:
22822219
25.

[Phase I study of nelarabine in patients with relapsed or refractory T-ALL/T-LBL].

Horibe K, Takimoto T, Yokozawa T, Makimoto A, Kobayashi Y, Ogawa C, Ohno R, Koh N, Katsura K, Tobinai K.

Rinsho Ketsueki. 2011 Jun;52(6):406-15.

PMID:
21737993
26.

Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2).

Yamamoto T, Nakamura H, Liu W, Cao K, Yoshikawa S, Enomoto H, Iwata Y, Koh N, Saito M, Imanishi H, Shimomura S, Iijima H, Hada T, Nishiguchi S.

J Gastroenterol. 2009;44(3):228-35. doi: 10.1007/s00535-008-2304-4. Epub 2009 Feb 13.

PMID:
19214667
27.
28.

Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection.

Enomoto M, Tamori A, Kohmoto MT, Hayashi T, Jomura H, Habu D, Sakaguchi H, Takeda T, Kawada N, Seki S, Shiomi S, Koh N, Nishiguchi S.

J Interferon Cytokine Res. 2007 Mar;27(3):201-7.

PMID:
17348818
29.

Quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Gutierrez JA, Dorocke JA, Knierman MD, Gelfanova V, Higgs RE, Koh NL, Hale JE.

Biotechniques. 2005 Jun;Suppl:13-7.

PMID:
16528911
30.

The genome sequence of Xanthomonas oryzae pathovar oryzae KACC10331, the bacterial blight pathogen of rice.

Lee BM, Park YJ, Park DS, Kang HW, Kim JG, Song ES, Park IC, Yoon UH, Hahn JH, Koo BS, Lee GB, Kim H, Park HS, Yoon KO, Kim JH, Jung CH, Koh NH, Seo JS, Go SJ.

Nucleic Acids Res. 2005 Jan 26;33(2):577-86. Print 2005.

31.

Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.

Tamori A, Nishiguchi S, Nishikawa M, Kubo S, Koh N, Hirohashi K, Shiomi S, Inoue M.

J Gastroenterol. 2004 Nov;39(11):1063-8.

PMID:
15580399
32.

p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection.

Narimatsu T, Tamori A, Koh N, Kubo S, Hirohashi K, Yano Y, Arakawa T, Otani S, Nishiguchi S.

Intervirology. 2004;47(1):26-31.

PMID:
15044833
33.

The challenge of providing holistic care in a viral epidemic: opportunities for palliative care.

Leong IY, Lee AO, Ng TW, Lee LB, Koh NY, Yap E, Guay S, Ng LM.

Palliat Med. 2004 Jan;18(1):12-8.

PMID:
14982202
34.

Cimetidine reduces impairment of cellular immunity after transcatheter arterial embolization in patients with hepatocellular carcinoma.

Nishiguchi S, Tamori A, Shiomi S, Enomoto M, Tatsumi N, Koh N, Habu D, Sakaguchi H, Takeda T, Seki S, Nakamura K, Kubo S, Kinoshita H.

Hepatogastroenterology. 2003 Mar-Apr;50(50):460-2.

PMID:
12749247
35.

Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection.

Tamori A, Nishiguchi S, Kubo S, Enomoto M, Koh N, Takeda T, Shiomi S, Hirohashi K, Kinoshita H, Otani S.

J Med Virol. 2003 Apr;69(4):475-81.

PMID:
12601754
36.

Transition metals and polyol pathway in the development of diabetic neuropathy in rats.

Nakamura J, Hamada Y, Chaya S, Nakashima E, Naruse K, Kato K, Yasuda Y, Kamiya H, Sakakibara F, Koh N, Hotta N.

Diabetes Metab Res Rev. 2002 Sep-Oct;18(5):395-402.

PMID:
12397582
37.

Polypharmacy in palliative care: can it be reduced?

Koh NY, Koo WH.

Singapore Med J. 2002 Jun;43(6):279-83.

PMID:
12380723
38.

Erythrocyte-binding polyamine as a tumor growth marker for human hepatocellular carcinoma.

Nishiguchi S, Tamori A, Koh N, Fujimoto S, Takeda T, Shiomi S, Oka H, Yano Y, Otani S, Kuroki T.

Hepatogastroenterology. 2002 Mar-Apr;49(44):504-7.

PMID:
11995483
39.

Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy.

Nakayama M, Nakamura J, Hamada Y, Chaya S, Mizubayashi R, Yasuda Y, Kamiya H, Koh N, Hotta N.

Diabetes Care. 2001 Jun;24(6):1093-8.

PMID:
11375376
40.

Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.

Moriyama Y, Nishiguchi S, Tamori A, Koh N, Yano Y, Kubo S, Hirohashi K, Otani S.

Clin Cancer Res. 2001 May;7(5):1293-8.

41.

Identification of genes differentially expressed by putrescine in HepG2 hepatoblastoma cells.

Fujimoto S, Yano Y, Nishiguchi S, Koh N, Tamori A, Shiomi S, Kuroki T, Otani S.

Hepatol Res. 2001 Jun;20(2):207-215.

PMID:
11348855
42.

Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.

Nishikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E, Inoue M.

Cancer Res. 2001 Mar 1;61(5):1843-5.

43.

Severely reduced production of klotho in human chronic renal failure kidney.

Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, Sugimura K, Kishimoto T, Kinoshita S, Kuroki T, Nabeshima Y.

Biochem Biophys Res Commun. 2001 Feb 2;280(4):1015-20.

PMID:
11162628
44.

Physiological and morphometric analyses of neuropathy in sucrose-fed OLETF rats.

Nakamura J, Hamada Y, Sakakibara F, Hara T, Wakao T, Mori K, Nakashima E, Naruse K, Kamijo M, Koh N, Hotta N.

Diabetes Res Clin Pract. 2001 Jan;51(1):9-20.

PMID:
11137177
45.

An aldose redutase inhibitor prevents the intimal thickening in coronary arteries of galactose-fed beagle dogs.

Kasuya Y, Ito M, Nakamura J, Hamada Y, Nakayama M, Chaya S, Komori T, Naruse K, Nakashima E, Kato K, Koh N, Hotta N.

Diabetologia. 1999 Dec;42(12):1404-9.

PMID:
10651257
46.

Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys.

Kato Y, Arakawa E, Kinoshita S, Shirai A, Furuya A, Yamano K, Nakamura K, Iida A, Anazawa H, Koh N, Iwano A, Imura A, Fujimori T, Kuro-o M, Hanai N, Takeshige K, Nabeshima Y.

Biochem Biophys Res Commun. 2000 Jan 19;267(2):597-602.

PMID:
10631108
47.

Ultrasonographic evaluation of portal blood flow using transhepatic carbon dioxide injection.

Sakaguchi H, Seki S, Tamori A, Gotoh T, Koh N, Kuroki T, Takashima S, Nakamura K, Yamada R.

Hepatogastroenterology. 1999 Jul-Aug;46(28):2249-53. Erratum in: Hepatogastroenterology 1999 Nov-Dec;46(30):followi.

PMID:
10521975
48.

A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.

Nakamura J, Kato K, Hamada Y, Nakayama M, Chaya S, Nakashima E, Naruse K, Kasuya Y, Mizubayashi R, Miwa K, Yasuda Y, Kamiya H, Ienaga K, Sakakibara F, Koh N, Hotta N.

Diabetes. 1999 Oct;48(10):2090-5.

PMID:
10512378
49.

Effect of vitamin E and allylamine on the proliferation of cultured aortic smooth muscle cells from streptozotocin-induced diabetic rats.

Sasaki H, Nakamura J, Koh N, Hamada Y, Hara T, Chaya S, Nakashima E, Naruse K, Kato K, Kasuya Y, Sakakibara F, Hotta N.

Life Sci. 1999;64(25):2317-25.

PMID:
10374895
50.

Relationship between ornithine decarboxylase gene abnormalities and human hepatocarcinogenesis.

Koh N, Tamori A, Nishiguchi S, Kuroki T, Seki S, Kobayashi K, Tanaka T, Kinoshita H, Yano Y, Otani S.

Hepatogastroenterology. 1999 Mar-Apr;46(26):1100-5.

PMID:
10370674

Supplemental Content

Support Center